Become a member of BioTechniques (it's free!) and receive the latest news in the life sciences, member-exclusives and 10% off BioTechniques article processing fees

Turning the tide on malaria: WHO approves the world’s first vaccine

Written by Storm Johnson (Commissioning Editor)

Malaria vaccine

A historic moment: WHO recommends deployment of a malaria vaccine finally developed after a 100-year endeavour.  

The WHO have advised that the RTS,S/AS01 vaccine, also known as Mosquirix, developed by GlaxoSmithKline (London, England) over the last 30 years in partnership with PATH (WA, USA), should be deployed among children in sub-Saharan Africa and other regions with moderate to high rates of Plasmodium falciparum transmission. The ongoing Malaria Vaccine Implementation Programme and rollout of the vaccine will “change African lives forever,” said Bello Abdul Hakeem Bolaji speaking to the BBC.

READ MORE ON INFECTIOUS DISEASES HUB NOW